Latest Breaking News On - Astrazeneca medimmune - Page 1 : comparemela.com

Tislelizumab plus chemotherapy versus placebo plus chemotherapy as first line treatment for advanced gastric or gastro-oesophageal junction adenocarcinoma: RATIONALE-305 randomised, double blind, phase 3 trial

Tislelizumab plus chemotherapy versus placebo plus chemotherapy as first line treatment for advanced gastric or gastro-oesophageal junction adenocarcinoma: RATIONALE-305 randomised, double blind, phase 3 trial
bmj.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from bmj.com Daily Mail and Mail on Sunday newspapers.

United-states
Japan
Taiwan
Junshi
Anhui
China
Helsinki
Eteläuomen-läi
Finland
Germany
Qilu
Gansu

Adagrasib, Cetuximab May Benefit KRASG12c Colorectal Cancer Patients

Adagrasib, Cetuximab May Benefit KRASG12c Colorectal Cancer Patients
miragenews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from miragenews.com Daily Mail and Mail on Sunday newspapers.

United-states
Texas
American
Redx-pharma
Daiichi-sankyo
Bristol-myers-squibb-medarex
Genentech-roche
Eli-lilly
Scott-kopetz
Navire-pharma
Astrazeneca-medimmune
Lutris-pharma

Adagrasib/Cetuximab Combo Has Activity in KRAS G12C+ Locally Advanced or mCRC

Adagrasib plus cetuximab elicited a 34% objective response rate in patients with previously treated KRAS G12C-mutant advanced colorectal cancer.

Texas
United-states
Houston
San-diego
California
American
Daiichi-sankyo
Bristol-meyers-squibb
Redx-pharma
Eli-lilly
Navire-pharma
Genentech-roche

Jay Bradner returns to lead R&D at Amgen—Chutes & Ladders

Jay Bradner returns to lead R&D at Amgen—Chutes & Ladders
fiercebiotech.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from fiercebiotech.com Daily Mail and Mail on Sunday newspapers.

Bancel
Rhôalpes
France
French
Rahul-kakkar
Astrazeneca-medimmune
Stephen-hoge
Chris-boshoff
Adam-rosenthal
Clay-siegall
Ruben-rodriguez
Jason-duncan

Poor oral health could lessen survival from h

An international study has revealed strong associations between oral health and survival among people diagnosed with head and neck cancer. Specifically, better oral health, as evidenced by the number of natural teeth and dental visits prior to the time of diagnosis, was associated with increased survival.

North-carolina
United-states
Argentina
Adams-school
Sao-paulo
Sãpaulo
Brazil
Barcelona
Comunidad-autonoma-de-cataluna
Spain
Tampa
Florida